Related Experiment Video
Updated: Jun 3, 2026

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries
Published on: September 6, 2012
Penicilloyl-polylysine stability and clinical use over time
Background:
The major penicillin skin test reagent, penicilloyl-polylysine, has not been commercially available since October 2004. The minimal concentration of penicilloyl-polylysine necessary for safe penicillin skin testing has not been determined.
Methods:
Penicillin skin testing was performed on 596 individuals between October 2004 and October 2006 using out-of-date commercially produced penicilloyl-polylysine as part of a complete panel of reagents. The concentration of active penicilloyl-polylysine was measured. Outcomes were compared with those for 921 individuals tested between October 2002 and September 2004 using in-date commercially produced penicilloyl-polylysine.
Results:
There was no significant difference in the fraction of patients who had positive skin test results using indate (5.1%) versus out-of-date (4.7%) penicilloyl-polylysine. There were four mild but no serious adverse reactions in the patients tested with the outdated reagent who were then challenged with oral penicillin class antibiotics.
Conclusion:
Penicillin skin testing can be safely done using penicilloyl-polylysine down to a concentration of 4.29 × 10(-5) M.
Related Concept Videos
Production of Antibiotics
Inhibitors of Gram-positive Cell Wall Synthesis
Drug Product Stability
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...

